Bioactivity of Carrageenans in Metabolic Syndrome and Cardiovascular Diseases

The high incidence of changes in the lipid profile world population is supported by adoption a lifestyle with numerous risk factors. Dyslipidemia, main alteration profile, characterized increased concentrations total cholesterol (TC), low-density lipoprotein (LDL-C), triglycerides (TG), and decreased concentration high-density (HDL-C). These modifications metabolism are particularities metabolic syndrome (MetS) one factors for development cardiovascular diseases (CVD), causes death world. Macroalgae have percentage dietary fiber, low lipids. Carrageenans, long-chain polysaccharides extracted from red macroalgae, present several foods, such as jelly. Chemically, they structures different applications purposes cosmetic, food, pharmaceutical industries. bioactive potential carrageenans has demonstrated reduction levels parameters being able to be an alternative reversion MetS and, consequently, prevention treatment CVD. This review article aims compile, evaluate, reflect on effect markers (TC, TG, HDL-C, LDL-C), relating them